The Company's patented platform technology, Electrical Nerve Block, is focused on elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post surgical pain, and chronic migraine.
Neuros Medical's technology, created by Drs. Kevin Kilgore and Niloy Bhadra of Case Western Reserve University's Department of Biomedical Engineering and MetroHealth Medical Center, and developed through funding from the National Institute of Biomedical Imaging and Bioengineering, delivers high-frequency stimulation to sensory nerves in the peripheral nervous system to block chronic pain. The system consists of an electrode (also known as a lead) placed around a peripheral nerve and powered by a pacemaker-size generator.
Chronic pain affects over 100 million Americans (Institute of Medicine - 2011) and is characterized as pain lasting more than 3 months in duration. The most common cause of neuropathic pain is pain from spine disorders. Another cause of neuropathic pain is diabetes, which may lead to damage of small nerves. Residual limb/neuroma pain is caused by trauma and neuroma development on the distal end of severed nerves, post limb amputation, impacting nearly 1 million Americans. Chronic migraine pain affects 25-30 million patients in the U.S. alone. Neuros Medical's technology also has an opportunity in treating patients with chronic post surgical pain. Chronic post surgical pain affects nearly 500,000 patients annually, and is experienced by patients following surgery. These procedures include hernia, thoracotomy, knee/hip repair, and mastectomy.
Latest funding size
Time since last funding
|9 months ago|
|U.S. Venture Partners (USVP), Rev1 Ventures, ECOTAF, JumpStart, RiverVest, Glengary Ventures, Aperture Venture Partners, North Coast Angel Fund, Osage University Partners, Case Technology Ventures, Ohio TechAngels Fund, Boston Scientific, Queen City Angels, Argonautic Ventures, BlueTree Allied Angels, iSELECT FUND|